136 related articles for article (PubMed ID: 37210016)
1. Correlation of Bcl-2 expression with prognosis and survival in patients with head and neck cancer: A systematic review and meta-analysis.
Silva FFVE; Caponio VCA; Camolesi GCV; Padín-Iruegas ME; Lorenzo-Pouso AI; Lima KC; Vieira SLS; Chamorro-Petronacci CM; Suaréz-Peñaranda JM; Pérez-Sayáns M
Crit Rev Oncol Hematol; 2023 Jul; 187():104021. PubMed ID: 37210016
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of programmed cell death ligand 1 expression in patients with head and neck cancer: A systematic review and meta-analysis.
Li J; Wang P; Xu Y
PLoS One; 2017; 12(6):e0179536. PubMed ID: 28604812
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of miRNAs in Head and Neck Cancers: A Comprehensive Systematic and Meta-Analysis.
Kumarasamy C; Madhav MR; Sabarimurugan S; Krishnan S; Baxi S; Gupta A; Gothandam KM; Jayaraj R
Cells; 2019 Jul; 8(8):. PubMed ID: 31349668
[TBL] [Abstract][Full Text] [Related]
4. Caspase 3 and Cleaved Caspase 3 Expression in Tumorogenesis and Its Correlations with Prognosis in Head and Neck Cancer: A Systematic Review and Meta-Analysis.
Silva FFVE; Padín-Iruegas ME; Caponio VCA; Lorenzo-Pouso AI; Saavedra-Nieves P; Chamorro-Petronacci CM; Suaréz-Peñaranda J; Pérez-Sayáns M
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233242
[TBL] [Abstract][Full Text] [Related]
5. mTOR pathway protein immunoexpression as a prognostic factor for survival in head and neck cancer patients: a systematic review and meta-analysis.
Marques AE; Elias ST; Porporatti AL; Castilho RM; Squarize CH; De Luca Canto G; Guerra EN
J Oral Pathol Med; 2016 May; 45(5):319-28. PubMed ID: 26661562
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis.
Yu Y; Wang H; Yan A; Wang H; Li X; Liu J; Li W
BMC Cancer; 2018 Apr; 18(1):383. PubMed ID: 29618336
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment prognostic nutritional index as a prognostic marker in head and neck cancer: a systematic review and meta-analysis.
Luan CW; Tsai YT; Yang HY; Chen KY; Chen PH; Chou HH
Sci Rep; 2021 Aug; 11(1):17117. PubMed ID: 34429476
[TBL] [Abstract][Full Text] [Related]
8. Aldehyde dehydrogenase serves as a biomarker for worse survival profiles in ovarian cancer patients: an updated meta-analysis.
Xia Y; Wei X; Gong H; Ni Y
BMC Womens Health; 2018 Dec; 18(1):199. PubMed ID: 30522488
[TBL] [Abstract][Full Text] [Related]
9. High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved.
Luo Y; Zhang X; Mo M; Tan Z; Huang L; Zhou H; Wang C; Wei F; Qiu X; He R; Chen G
Medicine (Baltimore); 2016 Apr; 95(15):e3337. PubMed ID: 27082587
[TBL] [Abstract][Full Text] [Related]
10. The lymphocyte-to-monocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysis.
Tham T; Olson C; Khaymovich J; Herman SW; Costantino PD
Eur Arch Otorhinolaryngol; 2018 Jul; 275(7):1663-1670. PubMed ID: 29651542
[TBL] [Abstract][Full Text] [Related]
11. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
[TBL] [Abstract][Full Text] [Related]
12. Metabolic tumor volume and total lesion glycolysis as prognostic factors in head and neck cancer: Systematic review and meta-analysis.
Rijo-Cedeño J; Mucientes J; Álvarez O; Royuela A; Seijas Marcos S; Romero J; García-Berrocal JR
Head Neck; 2020 Dec; 42(12):3744-3754. PubMed ID: 32914474
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of O6-methylguanine-DNA methyltransferase hypermethylation and expression in head and neck cancer: A systematic review and meta-analysis.
Yang H; Zhou L; Yang F; Chen J; Wang Y
Medicine (Baltimore); 2023 Apr; 102(14):e33472. PubMed ID: 37026932
[TBL] [Abstract][Full Text] [Related]
14. High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis.
Huang Q; Li S; Cheng P; Deng M; He X; Wang Z; Yang CH; Zhao XY; Huang J
World J Gastroenterol; 2017 Jul; 23(27):5018-5033. PubMed ID: 28785155
[TBL] [Abstract][Full Text] [Related]
15. Sex determining region Y-box 2 is a prognostic factor for head and neck squamous cell carcinoma: Evidence from 11 published investigations.
Li B; Chen M; Pan MX
J Cancer Res Ther; 2020; 16(3):434-439. PubMed ID: 32719247
[TBL] [Abstract][Full Text] [Related]
16. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
17. Survival Benefit of Metformin as an Adjuvant Treatment for Head and Neck Cancer: A Systematic Review and Meta-Analysis.
Jiao Y; Liu D; Sun Y; Chen Z; Liu S
Front Pharmacol; 2022; 13():850750. PubMed ID: 35645803
[No Abstract] [Full Text] [Related]
18. Prognostic role of E2F1 gene expression in human cancer: a meta-analysis.
Li J; Bi W; Lu F; Pan B; Xiong M; Nasifu L; Nie Z; He B
BMC Cancer; 2023 Jun; 23(1):509. PubMed ID: 37277745
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Prognostic Value of FDG PET/CT Parameters for Patients With Surgically Treated Head and Neck Cancer: A Systematic Review.
Creff G; Devillers A; Depeursinge A; Palard-Novello X; Acosta O; Jegoux F; Castelli J
JAMA Otolaryngol Head Neck Surg; 2020 May; 146(5):471-479. PubMed ID: 32215611
[TBL] [Abstract][Full Text] [Related]
20. Is E-cadherin immunoexpression a prognostic factor for head and neck squamous cell carcinoma (HNSCC)? A systematic review and meta-analysis.
Zhao Z; Ge J; Sun Y; Tian L; Lu J; Liu M; Zhao Y
Oral Oncol; 2012 Sep; 48(9):761-7. PubMed ID: 22455948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]